— RLX2™ CLINICAL RESEARCH —

The science behind Rilax

Researchers tested RLX2™, the finished, patent-pending formulation in Rilax®. They looked at how adults described their sleep.

2

Placebo-controlled clinical trials

What the studies found

Study 01 · 2019

Falling asleep and sleep disturbances

Malaysian Journal of Public Health Medicine

What researchers measured Illustration
Try to sleep Fall asleep
Time to fall asleep

At week four, the supplement group had better questionnaire scores for time to fall asleep and sleep disturbances than the placebo group.

The overall sleep score improved within the supplement group. The difference between groups was statistically inconclusive.

How the 2019 study worked

In this four-week trial, 70 adults were randomly assigned to take the supplement or a placebo. The reported results included 48 adults. Participants filled in a standard sleep questionnaire each week.

LiveLife Biosciences AG funded the study.

Read the 2019 study

Study 02 · 2022

Time asleep and sleep efficiency

Nutrients

What researchers measured Illustration
Awake Asleep Awake
Sleep efficiency = time asleep ÷ time in bed

Participants reported sleeping longer and spending a greater share of their time in bed asleep during the supplement period.

Both findings held across the two analyses.

How the 2022 study worked

The trial included 39 working adults with poor sleep quality. The same participants took the supplement and a placebo for four weeks each, in random order, with a one-week break between periods. Researchers also recorded brain activity while participants were awake.

The UTAR Research Fund and LiveLife Biosciences AG funded the study.

Read the 2022 study

Putting the findings in context. Both trials were short, involved small groups of adults and used self-reported sleep measures. Individual experiences can vary.

What this means for you

Rilax® is formulated to improve sleep quality and promote relaxation.

Explore Rilax